Aerie Pharmaceuticals, Inc. (AERI): Price and Financial Metrics

AERI POWR Grades

• AERI scores best on the Growth dimension, with a Growth rank ahead of 90.73% of US stocks.
• AERI's strongest trending metric is Value; it's been moving up over the last 179 days.
• AERI ranks lowest in Stability; there it ranks in the 2nd percentile.

AERI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for AERI is -11.2 -- better than merely 1.37% of US stocks.
• AERI's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 1.8% of US stocks.
• Revenue growth over the past 12 months for Aerie Pharmaceuticals Inc comes in at 133.51%, a number that bests 93.98% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Aerie Pharmaceuticals Inc are FUV, AFIB, RVNC, CLIR, and ACER.
• AERI's SEC filings can be seen here. And to visit Aerie Pharmaceuticals Inc's official web site, go to www.aeriepharma.com.

AERI Valuation Summary

• AERI's EV/EBIT ratio is -5.3; this is 118.09% lower than that of the median Healthcare stock.
• AERI's price/earnings ratio has moved up 7.8 over the prior 96 months.
• Over the past 96 months, AERI's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for AERI.

AERI Growth Metrics

Its 4 year cash and equivalents growth rate is now at 80.67%.
• The 4 year price growth rate now stands at -8.95%.
• Its 2 year net cashflow from operations growth rate is now at -31.52%.

Over the past 52 months, AERI's revenue has gone up $194,134,000.

The table below shows AERI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	194.134	-99.154	-74.81
2021-09-30	104.151	-46.682	-166.48
2021-06-30	94.919	-50.191	-166.437
2021-03-31	85.767	-52.922	-175.936
2020-12-31	83.138	-64.69	-183.101
2020-09-30	83.112	-114.176	-192.028

AERI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AERI has a Quality Grade of C, ranking ahead of 68.87% of graded US stocks.
• AERI's asset turnover comes in at 0.255 -- ranking 175th of 682 Pharmaceutical Products stocks.
• UTHR, AMGN, and AMRN are the stocks whose asset turnover ratios are most correlated with AERI.

The table below shows AERI's key quality metrics over time.